HEADER SIGNALING PROTEIN 29-JUN-11 3SO5 TITLE CRYSTAL STRUCTURE OF AN IMMUNOGLOBULIN I-SET DOMAIN OF LRIG3 PROTEIN TITLE 2 (LRIG3) FROM MUS MUSCULUS AT 1.70 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUCINE-RICH REPEATS AND IMMUNOGLOBULIN-LIKE DOMAINS COMPND 3 PROTEIN 3; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: IMMUNOGLOBULIN I-SET DOMAIN; COMPND 6 SYNONYM: LIG-3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: BC065142, KIAA3016, LRIG3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS IMMUNOGLOBULIN, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL KEYWDS 2 GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, SIGNALING KEYWDS 3 PROTEIN, PARTNERSHIP FOR STEM CELL BIOLOGY, STEMCELL EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG),PARTNERSHIP FOR STEM CELL AUTHOR 2 BIOLOGY (STEMCELL) REVDAT 4 01-FEB-23 3SO5 1 REMARK SEQADV LINK REVDAT 3 08-NOV-17 3SO5 1 REMARK REVDAT 2 21-OCT-15 3SO5 1 AUTHOR REVDAT 1 27-JUL-11 3SO5 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG), JRNL AUTH 2 PARTNERSHIP FOR STEM CELL BIOLOGY (STEMCELL) JRNL TITL CRYSTAL STRUCTURE OF AN IMMUNOGLOBULIN I-SET DOMAIN OF LRIG3 JRNL TITL 2 PROTEIN (LRIG3) FROM MUS MUSCULUS AT 1.70 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.8.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 26373 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1337 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.77 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2916 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2431 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2785 REMARK 3 BIN R VALUE (WORKING SET) : 0.2415 REMARK 3 BIN FREE R VALUE : 0.2758 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.49 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1679 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 193 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.03790 REMARK 3 B22 (A**2) : 3.03790 REMARK 3 B33 (A**2) : -6.07580 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1789 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2444 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 773 ; 6.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 50 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 273 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1789 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 6.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 243 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2085 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.18 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.58 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|496 - 600 } REMARK 3 ORIGIN FOR THE GROUP (A): -2.3994 6.8782 11.0967 REMARK 3 T TENSOR REMARK 3 T11: 0.0517 T22: -0.0630 REMARK 3 T33: -0.1622 T12: 0.0417 REMARK 3 T13: 0.0053 T23: -0.0103 REMARK 3 L TENSOR REMARK 3 L11: 3.0327 L22: 1.3401 REMARK 3 L33: 1.7493 L12: 0.0029 REMARK 3 L13: -0.5162 L23: -0.4354 REMARK 3 S TENSOR REMARK 3 S11: 0.1753 S12: 0.1700 S13: -0.1455 REMARK 3 S21: -0.1459 S22: -0.1154 S23: 0.0046 REMARK 3 S31: 0.2345 S32: 0.0955 S33: -0.0599 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|0 - 600 } REMARK 3 ORIGIN FOR THE GROUP (A): 21.1048 2.7096 15.2322 REMARK 3 T TENSOR REMARK 3 T11: 0.0275 T22: -0.1767 REMARK 3 T33: -0.1073 T12: -0.0325 REMARK 3 T13: -0.1909 T23: 0.0164 REMARK 3 L TENSOR REMARK 3 L11: 3.7605 L22: 1.4813 REMARK 3 L33: 1.7547 L12: 1.0366 REMARK 3 L13: 1.0260 L23: 0.2300 REMARK 3 S TENSOR REMARK 3 S11: 0.5241 S12: -0.1369 S13: -0.6925 REMARK 3 S21: 0.2133 S22: -0.0180 S23: -0.3889 REMARK 3 S31: 0.4952 S32: -0.0549 S33: -0.5061 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 3. SULFATE (SO4) AND CHLORIDE (CL) FROM THE REMARK 3 CRYSTALLIZATION AND THE PURIFICATION BUFFER RESPECTIVELY HAVE REMARK 3 BEEN MODELED INTO THE STRUCTURE. 4. NCS RESTRAINTS WERE APPLIED REMARK 3 USING BUSTER'S LSSR RESTRAINT REPRESENTATION (-AUTONCS). 5. THE REMARK 3 REFINEMENT WAS RESTRAINED AGAINST THE MAD PHASES. 6.THE PROTEIN REMARK 3 WAS SUBJECTED TO REDUCTIVE METHYLATION PRIOR TO CRYSTALLIZATION REMARK 3 AND LYSINES HAVE BEEN MODELED AS N-DIMETHYL-LYSINE (MLY). 7. REMARK 3 ELECTON DENSITY INDICATES THAT THE N-TERMINAL GLYCINE RESIDUE REMARK 3 (GLY 0) ON SUBUNIT B IS DI-METHYLATED; THEREFORE, THIS RESIDUE REMARK 3 WAS MODELED AS DIMETHYL GLYCINE (DMG). 8. DIFFERENCE ELECTRON REMARK 3 DENSITY IN A CRYSTAL PACKING INTERFACE NEAR GLU 547 COULD NOT BE REMARK 3 RELIABLY ASSIGNED AND WAS NOT MODELED. REMARK 4 REMARK 4 3SO5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000066443. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837,0.9792,0.97892 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26440 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 28.351 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06700 REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.63600 REMARK 200 R SYM FOR SHELL (I) : 0.63600 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5M SODIUM CHLORIDE, 0.2M LITHIUM REMARK 280 SULFATE, 0.1M SODIUM ACETATE PH 4.5, NANODROP, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.70250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 31.81700 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 31.81700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 85.05375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 31.81700 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 31.81700 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.35125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 31.81700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 31.81700 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 85.05375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 31.81700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 31.81700 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.35125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.70250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -74.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -31.81700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 31.81700 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 28.35125 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 DMG A 0 REMARK 465 GLY A 490 REMARK 465 PHE A 491 REMARK 465 VAL A 492 REMARK 465 CYS A 493 REMARK 465 ASP A 494 REMARK 465 ASP A 495 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 506 CG CD OE1 OE2 REMARK 470 MLY A 512 CH1 CH2 REMARK 470 GLU A 539 CD OE1 OE2 REMARK 470 MLY A 578 CH1 CH2 REMARK 470 MLY B 512 CG CD CE NZ CH1 CH2 REMARK 470 GLN B 542 CG CD OE1 NE2 REMARK 470 GLU B 572 CG CD OE1 OE2 REMARK 470 PHE B 573 CG CD1 CD2 CE1 CE2 CZ REMARK 470 THR B 574 OG1 CG2 REMARK 470 MLY B 578 CH1 CH2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 2004 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 421320 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 1. THE CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY RESIDUES 490-600 OF THE TARGET REMARK 999 SEQUENCE. 2. THE PROTEIN WAS REDUCTIVELY METHYLATED PRIOR TO REMARK 999 CRYSTALLIZATION. DBREF 3SO5 A 490 600 UNP Q6P1C6 LRIG3_MOUSE 490 600 DBREF 3SO5 B 490 600 UNP Q6P1C6 LRIG3_MOUSE 490 600 SEQADV 3SO5 DMG A 0 UNP Q6P1C6 EXPRESSION TAG SEQADV 3SO5 DMG B 0 UNP Q6P1C6 EXPRESSION TAG SEQRES 1 A 112 DMG GLY PHE VAL CYS ASP ASP PHE PRO MLY PRO GLN ILE SEQRES 2 A 112 THR VAL GLN PRO GLU THR GLN SER ALA ILE MLY GLY SER SEQRES 3 A 112 ASP VAL SER PHE THR CYS SER ALA ALA SER SER SER ASP SEQRES 4 A 112 SER PRO MSE THR PHE ALA TRP MLY MLY ASP ASN GLU ALA SEQRES 5 A 112 LEU GLN ASP ALA GLU MSE GLU ASN TYR ALA HIS LEU ARG SEQRES 6 A 112 ALA GLN GLY GLY GLU LEU MSE GLU TYR THR THR ILE LEU SEQRES 7 A 112 ARG LEU ARG ASN VAL GLU PHE THR SER GLU GLY MLY TYR SEQRES 8 A 112 GLN CYS VAL ILE SER ASN HIS PHE GLY SER SER TYR SER SEQRES 9 A 112 VAL MLY ALA MLY LEU THR ILE ASN SEQRES 1 B 112 DMG GLY PHE VAL CYS ASP ASP PHE PRO MLY PRO GLN ILE SEQRES 2 B 112 THR VAL GLN PRO GLU THR GLN SER ALA ILE MLY GLY SER SEQRES 3 B 112 ASP VAL SER PHE THR CYS SER ALA ALA SER SER SER ASP SEQRES 4 B 112 SER PRO MSE THR PHE ALA TRP MLY MLY ASP ASN GLU ALA SEQRES 5 B 112 LEU GLN ASP ALA GLU MSE GLU ASN TYR ALA HIS LEU ARG SEQRES 6 B 112 ALA GLN GLY GLY GLU LEU MSE GLU TYR THR THR ILE LEU SEQRES 7 B 112 ARG LEU ARG ASN VAL GLU PHE THR SER GLU GLY MLY TYR SEQRES 8 B 112 GLN CYS VAL ILE SER ASN HIS PHE GLY SER SER TYR SER SEQRES 9 B 112 VAL MLY ALA MLY LEU THR ILE ASN MODRES 3SO5 MLY A 498 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY A 512 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MSE A 530 MET SELENOMETHIONINE MODRES 3SO5 MLY A 535 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY A 536 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MSE A 546 MET SELENOMETHIONINE MODRES 3SO5 MSE A 560 MET SELENOMETHIONINE MODRES 3SO5 MLY A 578 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY A 594 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY A 596 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY B 498 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY B 512 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MSE B 530 MET SELENOMETHIONINE MODRES 3SO5 MLY B 535 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY B 536 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MSE B 546 MET SELENOMETHIONINE MODRES 3SO5 MSE B 560 MET SELENOMETHIONINE MODRES 3SO5 MLY B 578 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY B 594 LYS N-DIMETHYL-LYSINE MODRES 3SO5 MLY B 596 LYS N-DIMETHYL-LYSINE HET MLY A 498 11 HET MLY A 512 9 HET MSE A 530 13 HET MLY A 535 11 HET MLY A 536 11 HET MSE A 546 8 HET MSE A 560 8 HET MLY A 578 9 HET MLY A 594 11 HET MLY A 596 11 HET DMG B 0 6 HET MLY B 498 11 HET MLY B 512 5 HET MSE B 530 13 HET MLY B 535 11 HET MLY B 536 11 HET MSE B 546 8 HET MSE B 560 8 HET MLY B 578 9 HET MLY B 594 11 HET MLY B 596 11 HET SO4 A2002 5 HET CL A2003 1 HET CL A2005 1 HET CL A2006 1 HET SO4 B2001 5 HET CL B2004 1 HETNAM MLY N-DIMETHYL-LYSINE HETNAM MSE SELENOMETHIONINE HETNAM DMG N,N-DIMETHYLGLYCINE HETNAM SO4 SULFATE ION HETNAM CL CHLORIDE ION HETSYN DMG DIMETHYLGLYCINE FORMUL 1 MLY 14(C8 H18 N2 O2) FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 2 DMG C4 H9 N O2 FORMUL 3 SO4 2(O4 S 2-) FORMUL 4 CL 4(CL 1-) FORMUL 9 HOH *193(H2 O) HELIX 1 1 ARG A 553 GLY A 557 5 5 HELIX 2 2 GLU A 572 GLU A 576 5 5 HELIX 3 3 ARG B 553 GLY B 557 5 5 HELIX 4 4 GLU B 572 GLU B 576 5 5 SHEET 1 A 4 GLN A 500 VAL A 503 0 SHEET 2 A 4 VAL A 516 SER A 524 -1 O SER A 521 N THR A 502 SHEET 3 A 4 MSE A 560 LEU A 568 -1 O LEU A 568 N VAL A 516 SHEET 4 A 4 GLU A 545 HIS A 551 -1 N HIS A 551 O GLU A 561 SHEET 1 B 5 GLN A 508 ILE A 511 0 SHEET 2 B 5 ALA A 595 ASN A 600 1 O MLY A 596 N GLN A 508 SHEET 3 B 5 GLY A 577 ASN A 585 -1 N TYR A 579 O ALA A 595 SHEET 4 B 5 THR A 531 MLY A 536 -1 N ALA A 533 O VAL A 582 SHEET 5 B 5 GLU A 539 ALA A 540 -1 O GLU A 539 N MLY A 536 SHEET 1 C 4 GLN A 508 ILE A 511 0 SHEET 2 C 4 ALA A 595 ASN A 600 1 O MLY A 596 N GLN A 508 SHEET 3 C 4 GLY A 577 ASN A 585 -1 N TYR A 579 O ALA A 595 SHEET 4 C 4 GLY A 588 TYR A 591 -1 O SER A 590 N ILE A 583 SHEET 1 D 4 GLN B 500 VAL B 503 0 SHEET 2 D 4 VAL B 516 SER B 524 -1 O ALA B 523 N GLN B 500 SHEET 3 D 4 MSE B 560 LEU B 568 -1 O LEU B 568 N VAL B 516 SHEET 4 D 4 GLU B 545 HIS B 551 -1 N HIS B 551 O GLU B 561 SHEET 1 E 5 GLN B 508 ILE B 511 0 SHEET 2 E 5 ALA B 595 ASN B 600 1 O MLY B 596 N GLN B 508 SHEET 3 E 5 GLY B 577 ASN B 585 -1 N TYR B 579 O ALA B 595 SHEET 4 E 5 THR B 531 MLY B 536 -1 N ALA B 533 O VAL B 582 SHEET 5 E 5 GLU B 539 ALA B 540 -1 O GLU B 539 N MLY B 536 SHEET 1 F 4 GLN B 508 ILE B 511 0 SHEET 2 F 4 ALA B 595 ASN B 600 1 O MLY B 596 N GLN B 508 SHEET 3 F 4 GLY B 577 ASN B 585 -1 N TYR B 579 O ALA B 595 SHEET 4 F 4 GLY B 588 TYR B 591 -1 O SER B 590 N ILE B 583 LINK C PRO A 497 N MLY A 498 1555 1555 1.35 LINK C MLY A 498 N PRO A 499 1555 1555 1.34 LINK C ILE A 511 N MLY A 512 1555 1555 1.35 LINK C MLY A 512 N GLY A 513 1555 1555 1.33 LINK C PRO A 529 N MSE A 530 1555 1555 1.31 LINK C MSE A 530 N THR A 531 1555 1555 1.34 LINK C TRP A 534 N MLY A 535 1555 1555 1.33 LINK C MLY A 535 N MLY A 536 1555 1555 1.33 LINK C MLY A 536 N ASP A 537 1555 1555 1.34 LINK C GLU A 545 N MSE A 546 1555 1555 1.33 LINK C MSE A 546 N GLU A 547 1555 1555 1.33 LINK C LEU A 559 N MSE A 560 1555 1555 1.37 LINK C MSE A 560 N GLU A 561 1555 1555 1.35 LINK C GLY A 577 N MLY A 578 1555 1555 1.33 LINK C MLY A 578 N TYR A 579 1555 1555 1.34 LINK C VAL A 593 N MLY A 594 1555 1555 1.33 LINK C MLY A 594 N ALA A 595 1555 1555 1.33 LINK C ALA A 595 N MLY A 596 1555 1555 1.32 LINK C MLY A 596 N LEU A 597 1555 1555 1.34 LINK C PRO B 497 N MLY B 498 1555 1555 1.36 LINK C MLY B 498 N PRO B 499 1555 1555 1.35 LINK C ILE B 511 N MLY B 512 1555 1555 1.34 LINK C MLY B 512 N GLY B 513 1555 1555 1.33 LINK C PRO B 529 N MSE B 530 1555 1555 1.33 LINK C MSE B 530 N THR B 531 1555 1555 1.30 LINK C TRP B 534 N MLY B 535 1555 1555 1.33 LINK C MLY B 535 N MLY B 536 1555 1555 1.33 LINK C MLY B 536 N ASP B 537 1555 1555 1.36 LINK C GLU B 545 N MSE B 546 1555 1555 1.34 LINK C MSE B 546 N GLU B 547 1555 1555 1.33 LINK C LEU B 559 N MSE B 560 1555 1555 1.34 LINK C MSE B 560 N GLU B 561 1555 1555 1.33 LINK C GLY B 577 N MLY B 578 1555 1555 1.33 LINK C MLY B 578 N TYR B 579 1555 1555 1.34 LINK C VAL B 593 N MLY B 594 1555 1555 1.32 LINK C MLY B 594 N ALA B 595 1555 1555 1.33 LINK C ALA B 595 N MLY B 596 1555 1555 1.32 LINK C MLY B 596 N LEU B 597 1555 1555 1.33 SITE 1 AC1 8 ASN A 548 ALA A 550 HOH A2192 PHE B 532 SITE 2 AC1 8 ASN B 548 TYR B 549 ALA B 550 HOH B2081 SITE 1 AC2 5 PRO A 505 GLU A 506 PHE A 518 THR A 519 SITE 2 AC2 5 HOH A2037 SITE 1 AC3 2 ASP A 537 MLY A 594 SITE 1 AC4 3 MLY A 498 ILE A 501 HOH A2082 SITE 1 AC5 3 GLN A 555 ARG B 567 ARG B 569 SITE 1 AC6 3 GLU B 506 GLN B 508 THR B 519 CRYST1 63.634 63.634 113.405 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015715 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015715 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008818 0.00000